Single servings of coffee beverage containing low (412 µmol), medium (635 µmol) and high (795 µmol) amounts of chlorogenic acids were administered to eleven healthy volunteers in a double-blind randomised controlled trial. Analysis of plasma and urine collected for 24-h revealed the presence of 12 metabolites in plasma and 16 metabolites in urine, principally in the form of sulphates, and to a lesser extent glucuronides of caffeic, ferulic, dihydrocaffeic and dihydroferulic acids, as well as intact feruloylquinic and caffeoylquinic acids, and sulphated caffeoylquinic acid lactones. Median values of peak plasma concentrations after increasing doses of chlorogenic acids were 1088, 1526 and 1352 nM. In urine the median amounts of metabolites excreted after 24-h following consumption of the three coffees were 101, 160 and 125 µmol, accounting for 24%, 25% and 16% of the doses ingested. Peak plasma concentration and urinary excretion values showed trends towards a reduced bioavailability of chlorogenic acids associated with the highest dose ingested, when expressed as percentages of intake.
Introduction
Coffee is widely consumed throughout the world and the beverage contains high levels of chlorogenic acids with a single shot of espresso from commercial outlets providing between 24 and 422 mg. 1 Although occurring in a diversity of plantderived foods, coffee is the major dietary source of chlorogenic acids for many people. 2 Chlorogenic acids are a family of non-flavonoid compounds, comprising quinate esters of hydroxycinnamic acids such as caffeic, ferulic, and p-coumaric acids. The main chlorogenic acid classes in coffee are caffeoylquinic acids (CQAs), feruloylquinic acids (FQAs), p-coumaroylquinic acids (pCoQAs), dicaffeoylquinic acids (diCQAs), and caffeoylferuloylquinic acids (CFQAs). In addition, caffeoylquinic acid lactones (CQLs) and feruloylquinic acid lactones (FQLs), products of roasting, can also occur in coffee in significant amounts. 3 Depending on the position of the hydroxycinnamic acid on the quinic acid moiety, a wide range of different isomers occur in coffee, with the predominant compounds being 3-, 4-and 5-CQAs. 4 A limited number of studies have investigated the bioavailability of coffee chlorogenic acids in human subjects. Nardini et al. 5 reported an increase of conjugated caffeic acid in human plasma, reaching a maximum concentration 1 h after the ingestion of 200 mL of coffee. Increased amounts of ferulic acid, isoferulic acid, vanillic acid (3-methoxy-4-hydroxybenzoic acid), dihydroferulic acid, hippuric acid and 3-hydroxyhippuric acid were detected in urine samples of five male subjects, after three ingestions of two cups of coffee at 4 h intervals. 6 A wide range of metabolites produced in vivo after coffee intake or chlorogenic acids ingestion has been reported in previous detailed bioavailability studies along with only low nM levels of CQAs and FQAs appearing in plasma and urine ! in healthy subjects and volunteers with an ileostomy, and allowed distinguishing between events occurring in the small and large intestine. 7, 8 The low nM levels of CQAs and FQAs in plasma is also supported by other studies which have involved enzymic deglucuronidation and desulfation of the plasma samples. 9 The aim of the current study was to expand the earlier work of Stalmach et al. 7, 8 and to investigate the impact on the plasma pharmacokinetic profiles and urinary excretion of chlorogenic acid-derived metabolites after the acute ingestion by human volunteers of three instant coffees containing 412, 635 and 795 mol of chlorogenic acids per 200 mL serving.
Results

Analysis of coffees
The quantities of chlorogenic acids in 200 mL-servings of the three instant coffees (coffee I, II and III) fed to volunteers are summarised in Table 1. Identifications of the chlorogenic acids were based on MS 2 fragmentation patterns of ions at m/z 353 (CQAs) 1 , m/z 367 (FQAs), m/z 337 (p-CoQAs) and m/z 515 (diCQAs), according to Clifford et al. 10, 11 The identity of 3-and 4-CQAL was ascertained by both the MS 2 profiles of their ions at m/z 335 and cochromatography with standards. The levels of chlorogenic acids in the coffees ranged from 412 ± 9 to 795 ± 14 µmol, and consisted in CQAs (63 -74 %), FQAs (13 -18 %), CQALs (5 -14 %), diCQAs (3 -8 %) and p-CoQAs (1 -2 %). The 2fold difference between the highest and the lowest levels was mainly due to significantly greater amounts of CQAs, FQAs, diCQAs and p-CoQAs in coffee III There is much confusion over the names of caffeoylquinic acids with many suppliers, including Sigma, using non-IUPAC nomenclature. They refer to chlorogenic acid as 3-O-caffeoylquinic acid when it is 5-O-caffeoyquinic acid while their crytochorogenic acid, marketed as 5-O-caffeoyquinic acid, is the 3-O-isomer " which contained 795 ± 14 µmol of chlorogenic acids. Coffee II with intermediate levels of chlorogenic acids (635 ± 3 µmol) contained significantly more FQAs than the other two beverages (117 µmol compared to 103 and 67 µmol), as well as higher levels of lactones (77 µmol compared to 57 and 40 µmol) per serving (Table 1) .
Identification of chlorogenic acid derivatives and metabolites in plasma and urine samples
The identification and quantification of chlorogenic acid derivatives and metabolites circulating in plasma and excreted in urine was initially carried out on samples collected following the ingestion of coffee I, a commercial instant coffee that contains 412 µmol of chlorogenic acids per 200 mL serving. A total of 21 metabolites, principally sulphates and glucuronides were identified by HPLC-MS n in the 0-24 h plasma and urine samples. The identifications, summarised in Table 2 , were achieved using HPLC-MS 3 . The resulting MS 2 and MS 3 daughter ions were then compared to the fragmentation of either the available standards or, in the case of the chlorogenic acids, to their detailed, published MS n fragmentation patterns. 10, 11 The identity of metabolites of chlorogenic acids in plasma and urine samples was also ascertained by comparing their retention time with those of 3ʹ-O-and 4ʹ-O-sulphate and glucuronide standards. Full details of the basis of the identifications of the metabolites can be found in an earlier publication. 7 There are minor differences in the complex urinary metabolite profiles obtained in the two studies but this involves trace components, such a dihydroisoferulic acid-3′-O-glucuronide which was not detected in quantifiable amounts in the current investigation, rather than major metabolites. #
Chlorogenic acid intake and plasma metabolites
Twelve metabolites were detected in plasma following the ingestion of the three coffees containing different amounts of chlorogenic acids. Peak plasma concentrations (Cmax), time to reach Cmax (Tmax), area-under-the-curve (AUC) and apparent elimination half life 2 (T1/2) values were measured following increasing intakes. The pharmacokinetic parameters are summarised in Figure 1 and Table   3 .
The metabolic profile of the circulating chlorogenic acid metabolites can be divided into two distinct groups according to their time of appearance in plasma, following coffee intakes ( Figure 1 ). Intact feruloylquinic acids, as well as the sulphated lactones, 5-CQA and sulphated ferulic and caffeic acids reached peak plasma concentrations (Cmax) between 0.5 and 1.0 h after intake (Table 3 ). nmol.h.L -1 for dihydroferulic acid, respectively. The time to reach Cmax as well as T1/2 for each compound did not differ with the increasing doses. The only CQA that could be quantified in plasma was the main compound in the coffee beverage, namely 5-CQA, with Cmax of 11 (5.9; 13) nM following the intake of 795 µmol (Table 3) . 
Chlorogenic acid intake and urinary excretion of metabolites
Correlation between doses ingested and levels of metabolites in plasma and urine
Correlation between the doses of chlorogenic acids ingested and levels of parent compounds and metabolites quantified in plasma and urine after intake was assessed using Spearman's rank correlation and results are displayed in Table 5 .
Compounds and metabolites significantly associated with increasing doses of * chlorogenic acids administered were the FQAs and CQAL-S in both plasma and urine, with moderate to strong positive association (correlation coefficients ranging from 0.362 for 5-FQA in urine to 0.807 for 3-FQA in plasma, p < 0.05).
These metabolites showed an increase with the dose ingested, as shown in O-glucuronide also significantly increased with increasing intake of chlorogenic acids, with correlation coefficients of 0.409 (p = 0.018) and 0.507 (p = 0.003).
Discusssion
Following the ingestion of coffee there was extensive metabolism of chlorogenic acids. The probable pathways involved in the proximal and distal sections of the gastrointestinal tract, based on feeding studies with volunteers with and without an intact functioning colon, have been elucidated by Stalmach et al. 7, 8 Despite being major components in the coffee, and in contrast to the findings of Monteiro et al. 12 and Farah et al., 13 in the current study only trace amounts of one of the three CQAs, 5-CQA, appear in the circulatory system.
Plasma did however contain low levels of all three FQAs ( Figure 1 ) with absorption occurring, as with 5-CQA, in the small intestine. 5-CQA, which is stable when incubated with gastric juice, 6, 14 along with the other CQAs, is probably subjected to the action of esterases in the wall of the small intestine 15, 16 releasing caffeic acid which is converted to caffeic acid-3′-O-sulphate before entering the blood stream. It is possible that 3-and 4-CQAL and diCQAs could also be hydrolysed in the small intestine and contribute to the caffeic acid pool.
The rapid appearance of ferulic acid-4′-O-sulphate in plasma ( Fig. 1 ) could be the result of the FQAs following a parallel pathway being converted to ferulic acid FQAs, could also contribute to the ferulic acid pool. Most ferulic acid passes across the small intestine in the unmodified, unconjugated aglycone form, 17 implying that phase II sulphation of the hydroxycinnamate occurs mainly in the liver.
Analysis of ileal fluid collected after acute consumption of the lower dose by ileostomists indicated that in volunteers with a functioning colon ~70 % of the ingested chlorogenic acids will pass from the small to the large intestine, 8 also supported when higher amounts of chlorogenic acids were administered. 18 In vitro faecal fermentations have shown the breakdown of caffeoyl-and feruloylquinic acids, respectively, to caffeic acid and ferulic acid, which, via reduction of the 2,3 double bond on the aliphatic chain, are then converted to their dihydro derivatives by a bacterial reductase prior to phase II sulphation, and to a lesser degree glucuronidation, mediated by mammalian rather than bacterial enzymes. 19 The current study provides evidence of substantial absorption and metabolism in the colon, with Cmax values mostly well in excess of those obtained with compounds absorbed in the small intestine, being observed 4.0-6.0 h after coffee intake for dihydroferulic acid-4′-O-sulphate, dihydrocaffeic acid-3′-O-sulphate as well as dihydroferulic acid and dihydrocaffeic acid (Table   3 ).
The plasma pharmacokinetic data in Table 3 and Figure 1 Ludwig et al. 19 The large intestine is not a site for the in vivo sulphation of either hydroxycinnamates, 17 or flavonols. 20 or The sulphation of dihydrocaffeic acid and dihydroferulic acid, therefore, probably occurs in the liver after their absorption into the circulatory systems. The presence of substantial amounts of both free and sulphated dihydroferulic and dihydrocaffeic acids in plasma ( Fig.   1 ) is in keeping with this proposal.
Peak plasma concentrations and urinary excretion could be divided into metabolites absorbed in the small intestine and large intestine, and when expressed as a percent of intake, there was a significant trend towards a reduced absorption in the small intestine associated with the highest dose ingested (Table 6) . Similarly, urinary excretion of metabolites absorbed in the small intestine accounted for 5.9% (low dose), 5.4% (medium dose) and 3.9% (high dose), suggesting a reduced bioavailability of coffee chlorogenic acids after consumption of a higher dose. This is in line with a phenomenon noted by Erk et al. 18 or in an investigation with ileostomists, demonstrating an increased gastrointestinal transit time associated with the highest dose of chlorogenic acids ingested, albeit at doses that were 2.6 fold (low dose) and 5.7 fold (high dose) greater than those used in the current study. They observed an effect across all three doses, whereas in the current study, we observed a reduced bioavailability of coffee chlorogenic acids at the higher dose of chlorogenic acids In the current study, the urinary excretion levels of 3-FQA were consistently higher compared to those of 4-FQA and 5-FQA, across all three coffees (Fig. 2 ).
This may have resulted from either extensive in vivo isomerisation from 5-FQA to the 4-and 3-acyl, as previously observed in ileostomy volunteers 23 and/or from a preferential absorption with possible involvement of an active transport processed as discussed for the gastric absorption of 4-CQA and 4-FQA over the 5acyls. 21 Overall, the excretion of metabolites in urine after ingestion of chlorogenic acids ranged from 15.7 to 25.2 % of intake (Table 4) , indicating that the coffee chlorogenic acids are absorbed and excreted to a much greater extent than many other dietary flavonoids and phenolic compounds. 24 In the three coffee feeds total Cmax values were 1088 (759; 1372), 1526 (919; 2110) and 1352 (1211; 2291) . As noted in other studies with dietary (poly)phenolics this suggests that metabolites and related compounds absorbed into the circulatory system do not accumulate to any extent as they are treated by the body as xenobiotics and rapidly removed by renal excretion.
Biomarkers of (poly)phenol consumption may be a useful tool to assess dietary intake of certain compounds with potential benefits to human health, 25 The data obtained in the current study with coffee are summarised in Table 5 , and show that levels of FQAs and CQAL-O-sulphates in plasma and urine significantly and positively correlate with increasing intake of chlorogenic acids. These could serve as biomarkers of coffee intake, as their concentration in body fluids is sensitive to changes in coffee intake, and are also specific to coffee. 26 This is in contrast with the dihydrocaffeic acid and dihydroferulic acid metabolites, which are detected in a wide range of values between individual volunteers, and are also produced from a range of dietary (poly)phenolic compounds. 27, 28 The combined presence of these quinic acid ester metabolites in plasma and urine are convenient biomarkers of coffee consumption even after relatively low doses of intake.
Experimental
Chemicals
Ferulic acid, 5-CQA, dihydrocaffeic acid, sinapic acid, and L-ascorbic acid were Food & Function ! synthesized as described previously. 29 Feruloylglycine and isoferuloylglycine were prepared by methods outlined in an earlier publication. 8
Feeding study design
The feeding study was a double-blinded randomised cross-over trial with a washout period of two weeks between treatment, and involved healthy aliquots were stored at -80°C and, likewise, plasma samples were sub-divided into 1 ml aliquots which were stored at -80°C prior to analysis.
Analysis of coffee, plasma and urine
The instant coffees fed to the volunteers were supplied by the Nestlé Research Statistical significance was set at P-value < 0.05.
Conclusions
Coffee is a rich source of chlorogenic acids, principally 5-CQA, 4-CQA and 3-CQA. intakes. Further work should be carried out to determine the suitability of these compounds as biomarkers of chlorogenic acids/coffee intake in a wider population of free-living individuals without any dietary restrictions.
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